SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Boehringer Ingelheim Corporation and Eli Lilly and Company Release: Trajenta® (linagliptin) Receives Approval for the Treatment of Type 2 Diabetes in Europe